IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. IDL specializes in oncology and bacteriology. The company has a CE-marked product portfolio, used in healthcare, and established in various markets. In oncology, IDL uses various biomarkers, TK1, and cytokeratins, to support the treatment of various cancers such as breast, prostate, and bladder cancer. IDL's product portfolio also includes a rapid bacteriological test for a simple and safe diagnosis of typhoid fever. IDL (IDLDX) is listed on Nasdaq First North Growth Market with Redeye AB as Certified Adviser.
Company Details
- Employees
- 24
- Founded
- -
- Address
- Karlsbodavägen 39, Våning 5,sweden
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.idldiagnostics.com
- Keywords
- IT Consulting.
- HQ
- Bromma, Stockholm County
Idl Diagnostics Ab (Idldx) Questions
Idl Diagnostics Ab (Idldx)'s website is http://www.idldiagnostics.com
Idl Diagnostics Ab (Idldx)'s LinkedIn profile is https://se.linkedin.com/company/idldiagnostics
Idl Diagnostics Ab (Idldx) has
24 employees.
View email and phone details for 24
employees at Idl Diagnostics Ab (Idldx).
Idl Diagnostics Ab (Idldx)'s industry is
Medical Equipment Manufacturing
Idl Diagnostics Ab (Idldx)'s top competitors are
Pixelgen Technologies,
Atlas Antibodies,
Idl Biotech Ab(Publ),
Ccrm Nordic,
Lipigon Pharmaceuticals Ab,
Biovica International Ab,
Plantvision Ab,
Biolamina,
Estercare,
Northx Biologics.
Idl Diagnostics Ab (Idldx)'s categories are Medical Equipment Manufacturing
Idl Diagnostics Ab (Idldx)'s founding year is 2000
